gentamicin has been researched along with ellagic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Dey, D; Ghosh, S; Hazra, B; Ray, R | 1 |
| Aghsami, M; Ghahremani, MH; Keshavarz-Bahaghighat, H; Rajabi, J; Razavi-Azarkhiavi, K; Sepand, MR; Soodi, M | 1 |
| Abe, M; Aihara, KI; Hori, T; Kaneko, Y; Nakamura, S; Niimi, M; Okada, N; Sugasaki, M; Takishita, M; Yasui, S | 1 |
3 other study(ies) available for gentamicin and ellagic acid
| Article | Year |
|---|---|
Polyphenolic Secondary Metabolites Synergize the Activity of Commercial Antibiotics against Clinical Isolates of β-Lactamase-producing Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Caffeic Acids; Catechin; Ciprofloxacin; Drug Synergism; Ellagic Acid; Gentamicins; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phytochemicals; Polyphenols; Quercetin; Reserpine; Tetracycline | 2016 |
Ellagic acid confers protection against gentamicin-induced oxidative damage, mitochondrial dysfunction and apoptosis-related nephrotoxicity.
Topics: Animals; Anti-Bacterial Agents; Antioxidants; Apoptosis; Caspase 3; Creatinine; Cytochromes c; Ellagic Acid; Gentamicins; Glutathione; Kidney; Kidney Diseases; Lipid Peroxidation; Male; Membrane Potential, Mitochondrial; Mitochondria; Oxidative Stress; Phytotherapy; Plant Extracts; Rats, Sprague-Dawley; Superoxide Dismutase; Urea | 2016 |
Artifactual prolongation of the activated partial thromboplastin time by amikacin or gentamicin with ellagic acid, but not silica activated reagent.
Topics: Amikacin; Anti-Bacterial Agents; Ellagic Acid; Gentamicins; Humans; Indicators and Reagents; Partial Thromboplastin Time; Silicon Dioxide | 2022 |